These oncology cases also highlight a clear trend toward integrating multi‐omics data with sophisticated machine learning models to create predictive biomarkers that stratify patients and help identify tailored therapeutic options [ 73 , 74 ].
← all excerpts
A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).
1
—
—